IL200262A0 - Stabilized picoplatin oral form - Google Patents

Stabilized picoplatin oral form

Info

Publication number
IL200262A0
IL200262A0 IL200262A IL20026209A IL200262A0 IL 200262 A0 IL200262 A0 IL 200262A0 IL 200262 A IL200262 A IL 200262A IL 20026209 A IL20026209 A IL 20026209A IL 200262 A0 IL200262 A0 IL 200262A0
Authority
IL
Israel
Prior art keywords
oral form
stabilized picoplatin
picoplatin oral
stabilized
picoplatin
Prior art date
Application number
IL200262A
Original Assignee
Genzyme Corp
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Poniard Pharmaceuticals Inc filed Critical Genzyme Corp
Publication of IL200262A0 publication Critical patent/IL200262A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL200262A 2007-02-09 2009-08-06 Stabilized picoplatin oral form IL200262A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88917107P 2007-02-09 2007-02-09
US88968107P 2007-02-13 2007-02-13
PCT/US2008/001752 WO2008097661A1 (en) 2007-02-09 2008-02-08 Stabilized picoplatin oral dosage form

Publications (1)

Publication Number Publication Date
IL200262A0 true IL200262A0 (en) 2010-04-29

Family

ID=39682046

Family Applications (1)

Application Number Title Priority Date Filing Date
IL200262A IL200262A0 (en) 2007-02-09 2009-08-06 Stabilized picoplatin oral form

Country Status (12)

Country Link
EP (1) EP2114418A4 (en)
JP (1) JP2010518089A (en)
KR (1) KR20090109129A (en)
CN (2) CN101678046A (en)
AU (1) AU2008214202A1 (en)
BR (1) BRPI0806418A2 (en)
CA (1) CA2677640A1 (en)
HK (1) HK1206267A1 (en)
IL (1) IL200262A0 (en)
MX (1) MX2009008488A (en)
RU (1) RU2009133446A (en)
WO (1) WO2008097661A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20120148661A1 (en) * 2009-04-15 2012-06-14 Poniard Pharmaceuticals, Inc. High bioavailability oral picoplatin anti-cancer therapy
AU2015263884B2 (en) * 2014-05-23 2019-11-14 Mingsight Pharmaceuticals, Inc. Treatment of autoimmune disease
CN107778331B (en) * 2016-08-27 2020-06-30 鲁南制药集团股份有限公司 Purification method of picoplatin
CN108864177B (en) * 2018-04-20 2020-07-28 公安部物证鉴定中心 [2H3]Synthesis method of (E) -1-methylamino-2-phenyl propane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
HUP0204139A3 (en) * 2000-02-16 2003-07-28 Yamanouchi Pharma Co Ltd Use of n-[6-methoxi-5-(2-methoxiphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]-2phenyl-etienesulfonamide for producing pharmaceutical composition using for reducing pain in an endothelin-induced disease
WO2002085385A2 (en) * 2001-04-23 2002-10-31 Nucryst Pharmaceuticals Corp. Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
DE10141528B4 (en) * 2001-08-24 2006-08-10 Faustus Forschungs Cie. Translational Cancer Research Gmbh Platinum (II) and platinum (IV) complexes and their use
US20050119238A1 (en) * 2002-03-01 2005-06-02 Baron John A. Compositions and methods for preventing sporadic neoplasia in colon
WO2004006859A2 (en) * 2002-07-16 2004-01-22 Sonus Pharmaceuticals, Inc. Platinum compound
CN1681478A (en) * 2002-08-02 2005-10-12 川塞夫有限公司 Platinum aggregates and process for producing the same
CA2559722A1 (en) * 2004-03-18 2005-09-29 Transave, Inc. Administration of cisplatin by inhalation
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Also Published As

Publication number Publication date
AU2008214202A1 (en) 2008-08-14
BRPI0806418A2 (en) 2011-09-06
EP2114418A1 (en) 2009-11-11
CA2677640A1 (en) 2008-08-14
MX2009008488A (en) 2010-01-15
JP2010518089A (en) 2010-05-27
KR20090109129A (en) 2009-10-19
HK1206267A1 (en) 2016-01-08
CN104288119A (en) 2015-01-21
RU2009133446A (en) 2011-03-20
EP2114418A4 (en) 2013-01-09
WO2008097661A1 (en) 2008-08-14
CN101678046A (en) 2010-03-24

Similar Documents

Publication Publication Date Title
IL251175A0 (en) Stabilized picoplatin dosage form
EP2178893A4 (en) Oral formulations for picoplatin
ZA201101523B (en) Linaclotide-containing formulations for oral administration
HK1154484A1 (en) Oral dosage composition
GB0710439D0 (en) Oral dosage form
EP2133092A4 (en) Oral vaccine
EP2226071A4 (en) Composition for oral administration
HK1206267A1 (en) Stabilized picoplatin oral dosage form
HK1143533A1 (en) Foamable oral care composition
EP2263661A4 (en) Oral preparation
ZA201102446B (en) Oral formulation
IL200261A0 (en) Encapsulated picoplatin
HK1137363A1 (en) Novel dosage form
IL213559A0 (en) Oral formulations
HK1156844A1 (en) Pharmaceutical composition 271 271
EP2343059A4 (en) Oral preparation
IL198760A0 (en) Oral formulations
PL2046268T3 (en) Oral care composition
GB0822124D0 (en) Oral dosage form
EP2156842A4 (en) Oral composition
HU0700076D0 (en) New oral taxane formulations
GB0704123D0 (en) Dosage form
GB0712634D0 (en) New formulations
SI2271321T1 (en) Pharmaceutical composition 271